Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Oct 30:5:421.
doi: 10.3389/fphys.2014.00421. eCollection 2014.

O-GlcNAcylation, contractile protein modifications and calcium affinity in skeletal muscle

Affiliations
Review

O-GlcNAcylation, contractile protein modifications and calcium affinity in skeletal muscle

Caroline Cieniewski-Bernard et al. Front Physiol. .

Abstract

O-GlcNAcylation, a generally undermined atypical protein glycosylation process, is involved in a dynamic and highly regulated interplay with phosphorylation. Akin to phosphorylation, O-GlcNAcylation is also involved in the physiopathology of several acquired diseases, such as muscle insulin resistance or muscle atrophy. Recent data underline that the interplay between phosphorylation and O-GlcNAcylation acts as a modulator of skeletal muscle contractile activity. In particular, the O-GlcNAcylation level of the phosphoprotein myosin light chain 2 seems to be crucial in the modulation of the calcium activation properties, and should be responsible for changes in calcium properties observed in functional atrophy. Moreover, since several key structural proteins are O-GlcNAc-modified, and because of the localization of the enzymes involved in the O-GlcNAcylation/de-O-GlcNAcylation process to the nodal Z disk, a role of O-GlcNAcylation in the modulation of the sarcomeric structure should be considered.

Keywords: MLC2; O-GlcNAcylation; O-GlcNAcylation/phosphorylation interplay; contractile properties; contractile proteins; phosphorylation; sarcomeric structure.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Diagram showing various effects and implications of O-GlcNAcylation in skeletal muscle.

Similar articles

Cited by

References

    1. Ahmad I., Hoessli D. C., Walker-Nasir E., Choudhary M. I., Rafik S. M., Shakoori A. R., et al. . (2006). Phosphorylation and glycosylation interplay: protein modifications at hydroxy amino acids and prediction of signaling functions of the human beta3 integrin family. J. Cell. Biochem. 99, 706–718. 10.1002/jcb.20814 - DOI - PubMed
    1. Aoki H., Sadoshima J., Izumo S. (2000). Myosin light chain kinase mediates sarcomere organization during cardiac hypertrophy in vitro. Nat. Med. 6, 183–188. 10.1038/72287 - DOI - PubMed
    1. Arias E. B., Cartee G. D. (2005). Relationship between protein O-linked glycosylation and insulin-stimulated glucose transport in rat skeletal muscle following calorie restriction or exposure to O-(2-acetamido-2-deoxy-d-glucopyranosylidene)amino-N-phenylcarbamate. Acta Physiol. Scand. 183, 281–289. 10.1111/j.1365-201X.2004.01403.x - DOI - PubMed
    1. Baldwin K. M., White T. P., Arnaud S. B., Edgerton V. R., Kraemer W. J., Kram R., et al. . (1996). Musculoskeletal adaptations to weightlessness and development of effective countermeasures. Med. Sci. Sports Exerc. 28, 1247–1253. 10.1097/00005768-199610000-00007 - DOI - PubMed
    1. Blumenthal D. K., Stull J. T. (1980). Activation of skeletal muscle myosin light chain kinase by calcium(2+) and calmodulin. Biochemistry 19, 5608–5614. 10.1021/bi00565a023 - DOI - PubMed

LinkOut - more resources